Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 724.87 |
| Open | 723.48 |
| Bid | 733.40 x 1000 |
| Ask | 733.20 x 1100 |
| Day's Range | 721.00 - 737.45 |
| 52 Week Range | 392.26 - 800.78 |
| Volume | |
| Avg. Volume | 3,066,637 |
| Market Cap | 697.396B |
| Beta (5Y Monthly) | 0.37 |
| PE Ratio (TTM) | 126.47 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 5.20 (0.72%) |
| Ex-Dividend Date | Feb 14, 2024 |
| 1y Target Est | N/A |
- Investor's Business Daily
Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.
- Investor's Business Daily
How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
- Investor's Business Daily
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
© 2024 Yahoo. All rights reserved.